Module: colorectal-path
Module Contents
- colon-clinical-treatment
- 1.CENTER_NO
- 2.PERSON_ID
- 3.CRC1_TUMOR_NO
- 4.CRC1_ICD
- 5.CRC1_DXDATE
- 6.CRC1_SURG
- 7.CRC1_SURG_TYPE
- 8.CRC1_SURG_TYPE_TXT
- 9.CRC1_SURG_DATE
- 10.CRC1_SURG_LOCAL
- 11.CRC1_SURG_OTHORG
- 12.CRC1_SURG_OTHORG_SM_INTEST
- 13.CRC1_SURG_OTHORG_LIVER
- 14.CRC1_SURG_OTHORG_APPENDIX
- 15.CRC1_SURG_OTHORG_OVARY_NOS
- 16.CRC1_SURG_OTHORG_OVARY_R
- 17.CRC1_SURG_OTHORG_OVARY_L
- 18.CRC1_SURG_OTHORG_OVARY_B
- 19.CRC1_SURG_OTHORG_SPLEEN
- 20.CRC1_SURG_OTHORG_BLADDER
- 21.CRC1_SURG_OTHORG_OTH
- 22.CRC1_SURG_OTHORG_OTH_TXT
- 23.CRC1_SURG_MARGIN
- 24.CRC1_MET
- 25.CRC1_MET_ASCITES
- 26.CRC1_MET_MESEN_LN
- 27.CRC1_MET_LIVER
- 28.CRC1_MET_LUNG
- 29.CRC1_MET_OMENTUM
- 30.CRC1_MET_ABD_WALL
- 31.CRC1_MET_OVARY
- 32.CRC1_MET_BONE
- 33.CRC1_MET_PERITO
- 34.CRC1_MET_MESEN
- 35.CRC1_MET_OTH
- 36.CRC1_MET_OTH_TXT
- 37.CRC1_MET_RESECT
- 38.CRC1_MET_RESECT_DATE
- 39.CRC1_T
- 40.CRC1_N
- 41.CRC1_M
- 42.CRC1_T_SRC
- 43.CRC1_T_SRC_TXT
- 44.CRC1_N_SRC
- 45.CRC1_N_SRC_TXT
- 46.CRC1_M_SRC
- 47.CRC1_M_SRC_TXT
- 48.CRC1_CHEMO
- 49.CRC1_CHEMO_METHOD
- 50.CRC1_CHEMO1_DATE
- 51.CRC1_CHEMO1_AGT
- 52.CRC1_CHEMO1_AGT_5FU
- 53.CRC1_CHEMO1_AGT_FA
- 54.CRC1_CHEMO1_AGT_CPT11
- 55.CRC1_CHEMO1_AGT_OXAL
- 56.CRC1_CHEMO1_AGT_LEVA
- 57.CRC1_CHEMO1_AGT_XELO
- 58.CRC1_CHEMO1_AGT_AVAS
- 59.CRC1_CHEMO1_AGT_ERBI
- 60.CRC1_CHEMO1_AGT_GEMZ
- 61.CRC1_CHEMO1_AGT_OTH
- 62.CRC1_CHEMO1_AGT_OTH_TXT
- 63.CRC1_RAD
- 64.CRC1_RAD_METHOD
- 65.CRC1_RAD1_DATE
- 66.CRC1_TREAT_OTH
- 67.CRC1_TREAT_OTH_TXT
- 68.CRC1_SYNC
- 69.CRC1_SYNC_NUM
- 70.CRC1_SYNC2_TUMOR_NO
- 71.CRC1_SYNC2_ICD
- 72.CRC1_SYNC2_DXDATE
- 73.CRC1_SYNC2_SURG_TYPE
- 74.CRC1_SYNC2_SURG_TYPE_TXT
- 75.CRC1_SYNC2_SURG_LOCAL
- 76.CRC1_SYNC2_SURG_MARGIN
- 77.CRC1_SYNC3_TUMOR_NO
- 78.CRC1_SYNC3_ICD
- 79.CRC1_SYNC3_DXDATE
- 80.CRC1_SYNC3_SURG_TYPE
- 81.CRC1_SYNC3_SURG_TYPE_TXT
- 82.CRC1_SYNC3_SURG_LOCAL
- 83.CRC1_SYNC3_SURG_MARGIN
- 84.LR_RECUR
- 85.LR1_DATE
- 86.LR1_ANAST
- 87.LR1_MESEN
- 88.LR1_ABD_WALL
- 89.LR1_INCS
- 90.LR1_PELVIS
- 91.LR1_OTH
- 92.LR1_OTH_TXT
- 93.LR1_TREAT
- 94.LR1_SURG
- 95.LR1_SURG_LOCAL
- 96.LR1_SURG_TXT
- 97.LR1_CHEMO
- 98.LR1_CHEMO_METHOD
- 99.LR1_CHEMO1_DATE
- 100.LR1_CHEMO1_AGT
- 101.LR1_CHEMO1_AGT_5FU
- 102.LR1_CHEMO1_AGT_FA
- 103.LR1_CHEMO1_AGT_CPT11
- 104.LR1_CHEMO1_AGT_OXAL
- 105.LR1_CHEMO1_AGT_LEVA
- 106.LR1_CHEMO1_AGT_XELO
- 107.LR1_CHEMO1_AGT_AVAS
- 108.LR1_CHEMO1_AGT_ERBI
- 109.LR1_CHEMO1_AGT_GEMZ
- 110.LR1_CHEMO1_AGT_OTH
- 111.LR1_CHEMO1_AGT_OTH_TXT
- 112.LR1_RAD
- 113.LR1_RAD_METHOD
- 114.LR1_RAD1_DATE
- 115.LR1_TREAT_OTH
- 116.LR1_TREAT_OTH_TXT
- 117.LR_ADD
- 118.LR_ADD_ANAST
- 119.LR_ADD_ANAST_DATE
- 120.LR_ADD_MESEN
- 121.LR_ADD_MESEN_DATE
- 122.LR_ADD_ABD_WALL
- 123.LR_ADD_ABD_WALL_DATE
- 124.LR_ADD_INCS
- 125.LR_ADD_INCS_DATE
- 126.LR_ADD_PELVIS
- 127.LR_ADD_PELVIS_DATE
- 128.LR_ADD_OTH
- 129.LR_ADD_OTH_TXT
- 130.LR_ADD_OTH_DATE
- 131.DST_R
- 132.DST_R1_DATE
- 133.DST_R1_LIVER
- 134.DST_R1_LUNG
- 135.DST_R1_BONE
- 136.DST_R1_ASCITES
- 137.DST_R1_NONMES_LN
- 138.DST_R1_NONMES_LN_TXT
- 139.DST_R1_SUPRA_LN
- 140.DST_R1_BRAIN
- 141.DST_R1_SKIN
- 142.DST_R1_SKIN_TXT
- 143.DST_R1_ADRENAL
- 144.DST_R1_OTH
- 145.DST_R1_OTH_TXT
- 146.DST_R1_TREAT
- 147.DST_R1_SURG
- 148.DST_R1_SURG_LOCAL
- 149.DST_R1_SURG_TXT
- 150.DST_R1_CHEMO
- 151.DST_R1_CHEMO_METHOD
- 152.DST_R1_CHEMO1_DATE
- 153.DST_R1_CHEMO1_AGT
- 154.DST_R1_CHEMO1_AGT_5FU
- 155.DST_R1_CHEMO1_AGT_FA
- 156.DST_R1_CHEMO1_AGT_CPT11
- 157.DST_R1_CHEMO1_AGT_OXAL
- 158.DST_R1_CHEMO1_AGT_LEVA
- 159.DST_R1_CHEMO1_AGT_XELO
- 160.DST_R1_CHEMO1_AGT_AVAS
- 161.DST_R1_CHEMO1_AGT_ERBI
- 162.DST_R1_CHEMO1_AGT_GEMZ
- 163.DST_R1_CHEMO1_AGT_OTH
- 164.DST_R1_CHEMO1_AGT_OTH_TXT
- 165.DST_R1_RAD
- 166.DST_R1_RAD_METHOD
- 167.DST_R1_RAD1_DATE
- 168.DST_R_ADD
- 169.DST_R_ADD_LIVER
- 170.DST_R_ADD_LIVER_DATE
- 171.DST_R_ADD_LUNG
- 172.DST_R_ADD_LUNG_DATE
- 173.DST_R_ADD_BONE
- 174.DST_R_ADD_BONE_DATE
- 175.DST_R_ADD_ASCITES
- 176.DST_R_ADD_ASCITES_DATE
- 177.DST_R_ADD_NONMES_LN
- 178.DST_R_ADD_NONMES_LN_DATE
- 179.DST_R_ADD_NONMES_LN_TXT
- 180.DST_R_ADD_SUPRA_LN
- 181.DST_R_ADD_SUPRA_LN_DATE
- 182.DST_R_ADD_BRAIN
- 183.DST_R_ADD_BRAIN_DATE
- 184.DST_R_ADD_SKIN
- 185.DST_R_ADD_SKIN_DATE
- 186.DST_R_ADD_SKIN_TXT
- 187.DST_R_ADD_ADRENAL
- 188.DST_R_ADD_ADRENAL_DATE
- 189.DST_R_ADD_OTH
- 190.DST_R_ADD_OTH_DATE
- 191.DST_R_ADD_OTH_TXT
- 192.NEW_CRC_PRIM
- 193.NEW_CRC1_TUMOR_NO
- 194.NEW_CRC1_ICD
- 195.NEW_CRC1_DXDATE
- 196.NEW_CRC1_SURG
- 197.NEW_CRC1_SURG_TYPE
- 198.NEW_CRC1_SURG_TYPE_TXT
- 199.NEW_CRC1_SURG_DATE
- 200.NEW_CRC1_SURG_LOCAL
- 201.NEW_CRC1_SURG_OTHORG
- 202.NEW_CRC1_SURG_OTHORG_SM_INTEST
- 203.NEW_CRC1_SURG_OTHORG_LIVER
- 204.NEW_CRC1_SURG_OTHORG_APPENDIX
- 205.NEW_CRC1_SURG_OTHORG_OVARY_NOS
- 206.NEW_CRC1_SURG_OTHORG_OVARY_R
- 207.NEW_CRC1_SURG_OTHORG_OVARY_L
- 208.NEW_CRC1_SURG_OTHORG_OVARY_B
- 209.NEW_CRC1_SURG_OTHORG_SPLEEN
- 210.NEW_CRC1_SURG_OTHORG_BLADDER
- 211.NEW_CRC1_SURG_OTHORG_OTH
- 212.NEW_CRC1_SURG_OTHORG_OTH_TXT
- 213.NEW_CRC1_SURG_MARGIN
- 214.NEW_CRC1_MET
- 215.NEW_CRC1_MET_ASCITES
- 216.NEW_CRC1_MET_MESEN_LN
- 217.NEW_CRC1_MET_LIVER
- 218.NEW_CRC1_MET_LUNG
- 219.NEW_CRC1_MET_OMENTUM
- 220.NEW_CRC1_MET_ABD_WALL
- 221.NEW_CRC1_MET_OVARY
- 222.NEW_CRC1_MET_BONE
- 223.NEW_CRC1_MET_PERITO
- 224.NEW_CRC1_MET_MESEN
- 225.NEW_CRC1_MET_OTH
- 226.NEW_CRC1_MET_OTH_TXT
- 227.NEW_CRC1_MET_RESECT
- 228.NEW_CRC1_MET_RESECT_DATE
- 229.NEW_CRC1_T
- 230.NEW_CRC1_N
- 231.NEW_CRC1_M
- 232.NEW_CRC1_T_SRC
- 233.NEW_CRC1_T_SRC_TXT
- 234.NEW_CRC1_N_SRC
- 235.NEW_CRC1_N_SRC_TXT
- 236.NEW_CRC1_M_SRC
- 237.NEW_CRC1_M_SRC_TXT
- 238.NEW_CRC1_CHEMO
- 239.NEW_CRC1_CHEMO_METHOD
- 240.NEW_CRC1_CHEMO1_DATE
- 241.NEW_CRC1_CHEMO1_AGT
- 242.NEW_CRC1_CHEMO1_AGT_5FU
- 243.NEW_CRC1_CHEMO1_AGT_FA
- 244.NEW_CRC1_CHEMO1_AGT_CPT11
- 245.NEW_CRC1_CHEMO1_AGT_OXAL
- 246.NEW_CRC1_CHEMO1_AGT_LEVA
- 247.NEW_CRC1_CHEMO1_AGT_XELO
- 248.NEW_CRC1_CHEMO1_AGT_AVAS
- 249.NEW_CRC1_CHEMO1_AGT_ERBI
- 250.NEW_CRC1_CHEMO1_AGT_GEMZ
- 251.NEW_CRC1_CHEMO1_AGT_OTH
- 252.NEW_CRC1_CHEMO1_AGT_OTH_TXT
- 253.NEW_CRC1_RAD
- 254.NEW_CRC1_RAD_METHOD
- 255.NEW_CRC1_RAD1_DATE
- 256.NEW_CRC1_TREAT_OTH
- 257.NEW_CRC1_TREAT_OTH_TXT
- 258.NEW_CRC1_SYNC
- 259.NEW_CRC1_SYNC_NUM
- 260.NEW_CRC1_SYNC2_TUMOR_NO
- 261.NEW_CRC1_SYNC2_ICD
- 262.NEW_CRC1_SYNC2_DXDATE
- 263.NEW_CRC1_SYNC2_SURG_TYPE
- 264.NEW_CRC1_SYNC2_SURG_TYPE_TXT
- 265.NEW_CRC1_SYNC2_SURG_LOCAL
- 266.NEW_CRC1_SYNC2_SURG_MARGIN
- 267.NEW_CRC1_SYNC3_TUMOR_NO
- 268.NEW_CRC1_SYNC3_ICD
- 269.NEW_CRC1_SYNC3_DXDATE
- 270.NEW_CRC1_SYNC3_SURG_TYPE
- 271.NEW_CRC1_SYNC3_SURG_TYPE_TXT
- 272.NEW_CRC1_SYNC3_SURG_LOCAL
- 273.NEW_CRC1_SYNC3_SURG_MARGIN
- 274.NEW_CRC2_PRIM
- 275.NEW_CRC2_TUMOR_NO
- 276.NEW_CRC2_ICD
- 277.NEW_CRC2_DXDATE
- 278.NEW_CRC2_SURG_TYPE
- 279.NEW_CRC2_SURG_TYPE_TXT
- 280.NEW_CRC2_SURG_TYPE_LOCAL
- 281.NEW_CRC2_SURG_TYPE_MARGIN
- 282.NEW_CRC2_SYNC
- 283.NEW_CRC2_SYNC_NUM
- 284.NEW_NONCRC_PRIM
- 285.NEW_NONCRC1_ICD
- 286.NEW_NONCRC2_ICD
- 287.NEW_NONCRC3_ICD
- 288.LAST_STATUS
- 289.DEATH_DATE
- 290.DEATH_CAUSE
- 291.LAST_CHART_DATE
- 292.COMPLETE_DATE
- 293.LR_DST_RECUR
- 294.LR_DST1_ANAST
- 295.LR_DST1_ANAST_DATE
- 296.LR_DST1_MESEN
- 297.LR_DST1_MESEN_DATE
- 298.LR_DST1_ABD_WALL
- 299.LR_DST1_ABD_WALL_DATE
- 300.LR_DST1_INCS
- 301.LR_DST1_INCS_DATE
- 302.LR_DST1_PELVIS
- 303.LR_DST1_PELVIS_DATE
- 304.LR_DST1_LIVER
- 305.LR_DST1_LIVER_DATE
- 306.LR_DST1_LUNG
- 307.LR_DST1_LUNG_DATE
- 308.LR_DST1_BONE
- 309.LR_DST1_BONE_DATE
- 310.LR_DST1_ASCITES
- 311.LR_DST1_ASCITES_DATE
- 312.LR_DST1_NONMES_LN
- 313.LR_DST1_NONMES_LN_DATE
- 314.LR_DST1_NONMES_LN_TXT
- 315.LR_DST1_SUPRA_LN
- 316.LR_DST1_SUPRA_LN_DATE
- 317.LR_DST1_BRAIN
- 318.LR_DST1_BRAIN_DATE
- 319.LR_DST1_SKIN
- 320.LR_DST1_SKIN_DATE
- 321.LR_DST1_SKIN_TXT
- 322.LR_DST1_ADRENAL
- 323.LR_DST1_ADRENAL_DATE
- 324.LR_DST1_OTH
- 325.LR_DST1_OTH_TXT
- 326.LR_DST1_OTH_DATE
1 | CENTER_NO | number (2,0) | Required:true | ||||||||||||||||
Center identification number. | |||||||||||||||||||
|
2 | PERSON_ID | string (12) | Required:true |
Number that uniquely identifies an individual. |
3 | CRC1_TUMOR_NO | number (2,0) | Required:true |
PERSON_NO, TUMOR_NO uniquely identifies each tumor in the Informatics Centre. Tumor number should correspond with information from the CANCER file | |||
4 | CRC1_ICD | string (7) | Required:false |
ICD CODE: ICD0 code |
5 | CRC1_DXDATE | string (8) | Required:false | ||||||
Diagnosis Date Of First CRC Primary(s) in the Eligibility Period: | |||||||||
|
6 | CRC1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment performed | |||||||||||||
|
7 | CRC1_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||
Type of surgical treatment (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||
|
8 | CRC1_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgery |
9 | CRC1_SURG_DATE | string (8) | Required:false | ||||||
Date of 1st resection: | |||||||||
|
10 | CRC1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings indicating completeness of excision: (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
11 | CRC1_SURG_OTHORG | number (1,0) | Required:false | ||||||||||||
Were other organs (partial or total) removed at definitive surgery? | |||||||||||||||
|
12 | CRC1_SURG_OTHORG_SM_INTEST | number (1,0) | Required:false | ||||||
If small intestine (partial or total) were removed, please specify: | |||||||||
|
13 | CRC1_SURG_OTHORG_LIVER | number (1,0) | Required:false | ||||||
If liver (partial or total) was removed, please specify: | |||||||||
|
14 | CRC1_SURG_OTHORG_APPENDIX | number (1,0) | Required:false | ||||||
If appendix (partial or total) was removed, please specify: | |||||||||
|
15 | CRC1_SURG_OTHORG_OVARY_NOS | number (1,0) | Required:false | ||||||
If ovary (partial or total) were removed and no information on which side (left or right) , please specify: | |||||||||
|
16 | CRC1_SURG_OTHORG_OVARY_R | number (1,0) | Required:false | ||||||
If right ovary (partial or total) was removed, please specify: | |||||||||
|
17 | CRC1_SURG_OTHORG_OVARY_L | number (1,0) | Required:false | ||||||
If left ovary (partial or total) was removed, please specify: | |||||||||
|
18 | CRC1_SURG_OTHORG_OVARY_B | number (1,0) | Required:false | ||||||
If both ovaries (partial or total) were removed, please specify: | |||||||||
|
19 | CRC1_SURG_OTHORG_SPLEEN | number (1,0) | Required:false | ||||||
If spleen (partial or total) was removed, please specify: | |||||||||
|
20 | CRC1_SURG_OTHORG_BLADDER | number (1,0) | Required:false | ||||||
If bladder (partial or total) was removed, please specify: | |||||||||
|
21 | CRC1_SURG_OTHORG_OTH | number (1,0) | Required:false | ||||||
If other organs (partial or total) were removed, please specify: | |||||||||
|
22 | CRC1_SURG_OTHORG_OTH_TXT | string (250) | Required:false |
Free text describing other organs (partial or total) that were removed if more than one separate with commas |
23 | CRC1_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the tumor reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
24 | CRC1_MET | number (1,0) | Required:false | ||||||||||||
Metastatic Disease Found at the time of surgery (from perative report) | |||||||||||||||
|
25 | CRC1_MET_ASCITES | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: ASCITES | |||||||||
|
26 | CRC1_MET_MESEN_LN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesenteric lymph nodes, other than in mesentery of planned resection | |||||||||
|
27 | CRC1_MET_LIVER | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Liver | |||||||||
|
28 | CRC1_MET_LUNG | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Lung | |||||||||
|
29 | CRC1_MET_OMENTUM | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Omentum | |||||||||
|
30 | CRC1_MET_ABD_WALL | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Abdominal wall | |||||||||
|
31 | CRC1_MET_OVARY | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ovary(s) | |||||||||
|
32 | CRC1_MET_BONE | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Bone | |||||||||
|
33 | CRC1_MET_PERITO | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Peritoneum | |||||||||
|
34 | CRC1_MET_MESEN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesentery | |||||||||
|
35 | CRC1_MET_OTH | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Other | |||||||||
|
36 | CRC1_MET_OTH_TXT | string (250) | Required:false |
Free text describing other site of Metastatic Disease. If more than one separate with commas. |
37 | CRC1_MET_RESECT | number (1,0) | Required:false | ||||||||||||
Was this metastasis resected immediately (within 3 months) after baseline surgery) | |||||||||||||||
|
38 | CRC1_MET_RESECT_DATE | string (8) | Required:false | ||||||
Date metastasis was resected (only if metastasis was completely or incompletely resected) Month of metastasis resection: Day of metastasis resection: Year of metastasis resection: | |||||||||
|
39 | CRC1_T | number (1,0) | Required:false | ||||||||||||||||
Tumor Stage at Baseline (0-4) | |||||||||||||||||||
|
40 | CRC1_N | number (1,0) | Required:false | ||||||||||||
Nodal stage at Baseline (0-3) | |||||||||||||||
|
41 | CRC1_M | number (1,0) | Required:false | ||||||||||
Metastasis stage at Baseline (0-1) | |||||||||||||
|
42 | CRC1_T_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for tumor stage: | |||||||||||||||
|
43 | CRC1_T_SRC_TXT | string (250) | Required:false |
Source of information for tumor stage: OTHER |
44 | CRC1_N_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for nodal stage: | |||||||||||||||
|
45 | CRC1_N_SRC_TXT | string (250) | Required:false |
Source of information for nodal stage: OTHER |
46 | CRC1_M_SRC | number (1,0) | Required:false | ||||||||||||||||
Source of information for metastasis stage): | |||||||||||||||||||
|
47 | CRC1_M_SRC_TXT | string (250) | Required:false |
Source of information for metastasis stage):-OTHER |
48 | CRC1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for treatment of the primary colorectal cancer(s)? | |||||||||||||
|
49 | CRC1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the primary colorectal cancer(s)? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
50 | CRC1_CHEMO1_DATE | string (8) | Required:false | ||||||
Date of 1st chemotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||
|
51 | CRC1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall “missing/unknown agent” | |||||||||||
|
52 | CRC1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable “other” added to list additional drugs | |||||||||
|
53 | CRC1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
54 | CRC1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
55 | CRC1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
56 | CRC1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
57 | CRC1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
58 | CRC1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
59 | CRC1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
60 | CRC1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
61 | CRC1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT FOR BASELINE DIAGNOSIS | |||||||||
|
62 | CRC1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
NAME of OTHER AGENT, If more than one separate with commas. |
63 | CRC1_RAD | number (1,0) | Required:false | ||||||||||
Was radiation given for treatment of the primary colorectal cancer(s)? | |||||||||||||
|
64 | CRC1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the primary colorectal cancer(s)? | |||||||||||||||||
|
65 | CRC1_RAD1_DATE | string (8) | Required:false | ||||||
Date of 1st radiotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||
|
66 | CRC1_TREAT_OTH | number (1,0) | Required:false | ||||||||||||
Were other treatment methods applied for primary colorectal cancer(s)? | |||||||||||||||
|
67 | CRC1_TREAT_OTH_TXT | string (250) | Required:false |
Free text describing 1st other treatment. If more than one separate with commas. |
68 | CRC1_SYNC | number (1,0) | Required:false | ||||||
Were synchronous CRC primaries diagnosed at baseline? | |||||||||
|
69 | CRC1_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of SYNCHRONOUS PRIMARY(S) | |||||||||||
|
70 | CRC1_SYNC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
71 | CRC1_SYNC2_ICD | string (7) | Required:false |
ICD CODE of 2nd largest SYNCHRONOUS CRC PRIMARY (PRIMARY_2) : |
72 | CRC1_SYNC2_DXDATE | string (8) | Required:false | ||||||
DIAGNOSIS DATE OF 2nd SYNCHRONOUS CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||
|
73 | CRC1_SYNC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd synchronous primary CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
74 | CRC1_SYNC2_SURG_TYPE_TXT | string (250) | Required:false |
Surgical treatment for 2nd synchronous primary CRC (Can use SEER coding to derive) OTHER |
75 | CRC1_SYNC2_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 2nd synchronous primary CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
76 | CRC1_SYNC2_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 2nd synchronous primary CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
77 | CRC1_SYNC3_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
78 | CRC1_SYNC3_ICD | string (7) | Required:false |
ICD code for 3rd largest SYNCHRONOUS CRC PRIMARY (PRIMARY_3) |
79 | CRC1_SYNC3_DXDATE | string (8) | Required:false | ||||||
DIAGNOSIS DATE OF 3rd SYNCHRONOUS CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||
|
80 | CRC1_SYNC3_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 3rd synchronous primary CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
81 | CRC1_SYNC3_SURG_TYPE_TXT | string (250) | Required:false |
Surgical treatment for 3rd synchronous primary CRC (Can use SEER coding to derive) OTHER |
82 | CRC1_SYNC3_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 3rd synchronous primary CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
83 | CRC1_SYNC3_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 3rd synchronous primary CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
84 | LR_RECUR | number (1,0) | Required:true | ||||||||||||
Did the patient have at least one locoregional recurrence after CRC diagnosis? (Ideally interval between diagnosis date and final chart review date should be at least 4 years) | |||||||||||||||
|
85 | LR1_DATE | string (8) | Required:false | ||||||
Date of 1st locoregional recurrence | |||||||||
|
86 | LR1_ANAST | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Anastomosis: | |||||||||
|
87 | LR1_MESEN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Mesentery | |||||||||
|
88 | LR1_ABD_WALL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Abdominal Wall (not incisional) | |||||||||
|
89 | LR1_INCS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Incisional | |||||||||
|
90 | LR1_PELVIS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Pelvis | |||||||||
|
91 | LR1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): OTHER | |||||||||
|
92 | LR1_OTH_TXT | string (250) | Required:false |
LocoRegional Recurrence 1st other site Comma separated list of other site(s) |
93 | LR1_TREAT | number (1,0) | Required:false | ||||||||||
Did patient receive treatment for locoregional recurrence? | |||||||||||||
|
94 | LR1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment given for locoregional recurrence? | |||||||||||||
|
95 | LR1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Surgery for locoregional recurrence: | |||||||||||||
|
96 | LR1_SURG_TXT | string (250) | Required:false |
If Surgery for locoregional recurrence: 1 or 2, then specify (describe procedure ?text format) |
97 | LR1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for locoregional recurrence? | |||||||||||||
|
98 | LR1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the locoregional recurrence(s) Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
99 | LR1_CHEMO1_DATE | string (8) | Required:false | ||||||
Date of 1st chemotherapy treatment of the locoregional recurrence. | |||||||||
|
100 | LR1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall “missing/unknown agent” | |||||||||||
|
101 | LR1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable “other” added to list additional drugs | |||||||||
|
102 | LR1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
103 | LR1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
104 | LR1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
105 | LR1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
106 | LR1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
107 | LR1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
108 | LR1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
109 | LR1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
110 | LR1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
111 | LR1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT for first locoregional recurrence diagnosis. If more than one separate with commas. |
112 | LR1_RAD | number (1,0) | Required:false | ||||||||||
Was radiotherapy given for locoregional recurrence? | |||||||||||||
|
113 | LR1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the locoregional recurrence? | |||||||||||||||||
|
114 | LR1_RAD1_DATE | string (8) | Required:false | ||||||
Date of 1st radiotherapy treatment of the locoregional recurrence. | |||||||||
|
115 | LR1_TREAT_OTH | number (1,0) | Required:false | ||||||||||||
Were other treatment methods applied for first locoregional recurrence? | |||||||||||||||
|
116 | LR1_TREAT_OTH_TXT | string (250) | Required:false |
Free text describing first other treatment methods applied for first locoregional recurrence. Comma separated list of other agents(s |
117 | LR_ADD | number (1,0) | Required:false | ||||||||||||
Pseudo entry question to section on additional LR sites, ie should be yes if any LR_ADD below are yes. | |||||||||||||||
|
118 | LR_ADD_ANAST | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Anastomosis: | |||||||||
|
119 | LR_ADD_ANAST_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
120 | LR_ADD_MESEN | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Mesentery | |||||||||
|
121 | LR_ADD_MESEN_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
122 | LR_ADD_ABD_WALL | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Abdominal Wall (not incisional) | |||||||||
|
123 | LR_ADD_ABD_WALL_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
124 | LR_ADD_INCS | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Incisional | |||||||||
|
125 | LR_ADD_INCS_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
126 | LR_ADD_PELVIS | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Pelvis | |||||||||
|
127 | LR_ADD_PELVIS_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
128 | LR_ADD_OTH | number (1,0) | Required:false | ||||||
Locoregional recurrence site(s) after the 1st site(s) identified Other | |||||||||
|
129 | LR_ADD_OTH_TXT | string (250) | Required:false |
Free text describing additional LR site |
130 | LR_ADD_OTH_DATE | string (8) | Required:false | ||||||
Diagnosed Month Diagnosed Day (optional) Diagnosed Year | |||||||||
|
131 | DST_R | number (1,0) | Required:true | ||||||||||||
Did the patient have a distant recurrence after CRC diagnosis (after start date to final chart date available)? | |||||||||||||||
|
132 | DST_R1_DATE | string (8) | Required:false | ||||||
Date of first distant recurrence | |||||||||
|
133 | DST_R1_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Liver | |||||||||
|
134 | DST_R1_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Lung | |||||||||
|
135 | DST_R1_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Bone | |||||||||
|
136 | DST_R1_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Ascites | |||||||||
|
137 | DST_R1_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Non mesenteric lymph nodes (except supraclavicular) | |||||||||
|
138 | DST_R1_NONMES_LN_TXT | string (250) | Required:false |
Free text describing specific non mesenteric lymph nodes (except supraclavicular) |
139 | DST_R1_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Supraclavicular nodes | |||||||||
|
140 | DST_R1_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Brain | |||||||||
|
141 | DST_R1_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence: Skin, except incision Specify site (text): | |||||||||
|
142 | DST_R1_SKIN_TXT | string (250) | Required:false | ||||||
Free text describing specific skin site of first distant recurrence | |||||||||
|
143 | DST_R1_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence: Adrenal gland | |||||||||
|
144 | DST_R1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant recurrence Other Specify site (text): | |||||||||
|
145 | DST_R1_OTH_TXT | string (250) | Required:false |
Free text describing other site of first distant recurrence |
146 | DST_R1_TREAT | number (1,0) | Required:false | ||||||||||
Did the patient undergo treatment for distant recurrence?: | |||||||||||||
|
147 | DST_R1_SURG | number (1,0) | Required:false | ||||||||||
Did patient undergo surgical treatment for distant recurrence? | |||||||||||||
|
148 | DST_R1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Surgery for distant recurrence | |||||||||||||
|
149 | DST_R1_SURG_TXT | string (250) | Required:false |
Free text describing other surgery for distant recurrence 1 or 2 |
150 | DST_R1_CHEMO | number (1,0) | Required:false | ||||||||||
Did patient undergo chemotherapy for distant recurrence? | |||||||||||||
|
151 | DST_R1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
If chemotherapy was given, what method of chemotherapy was applied for treatment of the distant recurrence? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
152 | DST_R1_CHEMO1_DATE | string (8) | Required:false | ||||||
Date of 1st chemotherapy treatment of the distant recurrence. | |||||||||
|
153 | DST_R1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall “missing/unknown agent | |||||||||||
|
154 | DST_R1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable “other” added to list additional drugs | |||||||||
|
155 | DST_R1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
156 | DST_R1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
157 | DST_R1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
158 | DST_R1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
159 | DST_R1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
160 | DST_R1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
161 | DST_R1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
162 | DST_R1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
163 | DST_R1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
164 | DST_R1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT for distant recurrence diagnosis. If more than one separate with commas. |
165 | DST_R1_RAD | number (1,0) | Required:false | ||||||||||
Was radiotherapy treatment given for distant recurrence? | |||||||||||||
|
166 | DST_R1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the 1st distant recurrence? | |||||||||||||||||
|
167 | DST_R1_RAD1_DATE | string (8) | Required:false | ||||||
Date of 1st radiotherapy treatment of the distant recurrence. | |||||||||
|
168 | DST_R_ADD | number (1,0) | Required:false | ||||||||||||
pseudo gateway for additional distant recurrence site(s) | |||||||||||||||
|
169 | DST_R_ADD_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Liver | |||||||||
|
170 | DST_R_ADD_LIVER_DATE | string (8) | Required:false | ||||||
Additional Distant Recurrence First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
171 | DST_R_ADD_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Lung | |||||||||
|
172 | DST_R_ADD_LUNG_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
173 | DST_R_ADD_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Bone | |||||||||
|
174 | DST_R_ADD_BONE_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
175 | DST_R_ADD_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Ascites | |||||||||
|
176 | DST_R_ADD_ASCITES_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
177 | DST_R_ADD_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Non mesenteric lymph nodes (except supraclavicular) | |||||||||
|
178 | DST_R_ADD_NONMES_LN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
179 | DST_R_ADD_NONMES_LN_TXT | string (250) | Required:false |
Free test describing non-mesenteric lymph nodes (except supraclavicular) involved in additional distant recurrence |
180 | DST_R_ADD_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Supraclavicular nodes | |||||||||
|
181 | DST_R_ADD_SUPRA_LN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
182 | DST_R_ADD_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Brain | |||||||||
|
183 | DST_R_ADD_BRAIN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
184 | DST_R_ADD_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Skin, except incision Specify site (text): | |||||||||
|
185 | DST_R_ADD_SKIN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
186 | DST_R_ADD_SKIN_TXT | string (250) | Required:false |
Free text describing site of additional distant recurrence in skin |
187 | DST_R_ADD_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Adrenal gland | |||||||||
|
188 | DST_R_ADD_ADRENAL_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
189 | DST_R_ADD_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of additional distant recurrence Other Specify site (text): | |||||||||
|
190 | DST_R_ADD_OTH_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
191 | DST_R_ADD_OTH_TXT | string (250) | Required:false |
Free text describing other site of additional distant recurrence |
192 | NEW_CRC_PRIM | number (1,0) | Required:true | ||||||||||
Did the proband have a new primary colorectal cancer diagnosis after the original CRC diagnosis (after start date to final chart date)? NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
193 | NEW_CRC1_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
194 | NEW_CRC1_ICD | string (7) | Required:false |
ICD code of 1st new CRC PRIMARY If SYNCHRONOUS primaries, please record the LARGEST. (NEW_PRIMARY_1) |
195 | NEW_CRC1_DXDATE | string (8) | Required:false | ||||||
DIAGNOSIS DATE OF 1st New CRC PRIMARY | |||||||||
|
196 | NEW_CRC1_SURG | number (1,0) | Required:false | ||||||||||
Surgical treatment performed for 1st New CRC PRIMARY? | |||||||||||||
|
197 | NEW_CRC1_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||
Type of surgical treatment for new CRC primary (Can use SEER coding) | |||||||||||||||||||||||||||||||||
|
198 | NEW_CRC1_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other type of surgery for 1st new CRC primary |
199 | NEW_CRC1_SURG_DATE | string (8) | Required:false | ||||||
Date of 1st resection for 1st new CRC primary | |||||||||
|
200 | NEW_CRC1_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) for 1st new CRC primary (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
201 | NEW_CRC1_SURG_OTHORG | number (1,0) | Required:false | ||||||||||||
Were other organs (partial or total) removed at definitive surgery for 1st new CRC primary ? | |||||||||||||||
|
202 | NEW_CRC1_SURG_OTHORG_SM_INTEST | number (1,0) | Required:false | ||||||
If small intestine (partial or total) were removed, please specify: | |||||||||
|
203 | NEW_CRC1_SURG_OTHORG_LIVER | number (1,0) | Required:false | ||||||
If liver (partial or total) was removed, please specify: | |||||||||
|
204 | NEW_CRC1_SURG_OTHORG_APPENDIX | number (1,0) | Required:false | ||||||
If appendix (partial or total) was removed, please specify: | |||||||||
|
205 | NEW_CRC1_SURG_OTHORG_OVARY_NOS | number (1,0) | Required:false | ||||||
If ovary (partial or total) were removed and no information on which side (left or right) , please specify: | |||||||||
|
206 | NEW_CRC1_SURG_OTHORG_OVARY_R | number (1,0) | Required:false | ||||||
If right ovary (partial or total) was removed, please specify: | |||||||||
|
207 | NEW_CRC1_SURG_OTHORG_OVARY_L | number (1,0) | Required:false | ||||||
If left ovary (partial or total) was removed, please specify: | |||||||||
|
208 | NEW_CRC1_SURG_OTHORG_OVARY_B | number (1,0) | Required:false | ||||||
If both ovaries (partial or total) were removed, please specify: | |||||||||
|
209 | NEW_CRC1_SURG_OTHORG_SPLEEN | number (1,0) | Required:false | ||||||
If spleen (partial or total) was removed, please specify: | |||||||||
|
210 | NEW_CRC1_SURG_OTHORG_BLADDER | number (1,0) | Required:false | ||||||
If bladder (partial or total) was removed, please specify: | |||||||||
|
211 | NEW_CRC1_SURG_OTHORG_OTH | number (1,0) | Required:false | ||||||
If other organs (partial or total) were removed, please specify: | |||||||||
|
212 | NEW_CRC1_SURG_OTHORG_OTH_TXT | string (250) | Required:false |
Free text describing other organs (partial or total) removed COMMA SEPERATED IF MORE THAN ONE |
213 | NEW_CRC1_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 1st new CRC primary reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
214 | NEW_CRC1_MET | number (1,0) | Required:false | ||||||||||||
Was distant metastatic disease found at surgery for 1st new CRC primary? | |||||||||||||||
|
215 | NEW_CRC1_MET_ASCITES | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ascites | |||||||||
|
216 | NEW_CRC1_MET_MESEN_LN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesenteric lymph nodes, other than in mesentery of planned resection | |||||||||
|
217 | NEW_CRC1_MET_LIVER | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Liver | |||||||||
|
218 | NEW_CRC1_MET_LUNG | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Lung | |||||||||
|
219 | NEW_CRC1_MET_OMENTUM | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Omentum | |||||||||
|
220 | NEW_CRC1_MET_ABD_WALL | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Abdominal wall | |||||||||
|
221 | NEW_CRC1_MET_OVARY | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Ovary(s) | |||||||||
|
222 | NEW_CRC1_MET_BONE | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Bone | |||||||||
|
223 | NEW_CRC1_MET_PERITO | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Peritoneum | |||||||||
|
224 | NEW_CRC1_MET_MESEN | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Mesentery | |||||||||
|
225 | NEW_CRC1_MET_OTH | number (1,0) | Required:false | ||||||
Site of Metastatic Disease: Other | |||||||||
|
226 | NEW_CRC1_MET_OTH_TXT | string (250) | Required:false |
Free text describing other site of Metastatic Disease COMMA SEPERATED IF MORE THAN ONE |
227 | NEW_CRC1_MET_RESECT | number (1,0) | Required:false | ||||||||||||
Was this metastasis resected immediately (within 3 months) after baseline surgery) (if applicable) | |||||||||||||||
|
228 | NEW_CRC1_MET_RESECT_DATE | string (8) | Required:false | ||||||
Date metastasis was resected (only if metastasis was completely or incompletely resected): | |||||||||
|
229 | NEW_CRC1_T | number (1,0) | Required:false | ||||||||||||||||
Clinicopathologic summary stage of disease. Tumor Stage of 1st new CRC primary (0-4) | |||||||||||||||||||
|
230 | NEW_CRC1_N | number (1,0) | Required:false | ||||||||||||
Nodal stage of 1st new CRC primary (0-3) | |||||||||||||||
|
231 | NEW_CRC1_M | number (1,0) | Required:false | ||||||||||
Metastasis stage of 1st new CRC primary (0-1) | |||||||||||||
|
232 | NEW_CRC1_T_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for tumor stage: | |||||||||||||||
|
233 | NEW_CRC1_T_SRC_TXT | string (250) | Required:false |
Source of information for tumor stage: OTHER |
234 | NEW_CRC1_N_SRC | number (1,0) | Required:false | ||||||||||||
Source of information for nodal stage: | |||||||||||||||
|
235 | NEW_CRC1_N_SRC_TXT | string (250) | Required:false |
Source of information for nodal stage: OTHER |
236 | NEW_CRC1_M_SRC | number (1,0) | Required:false | ||||||||||||||||
Source of information for metastasis stage): | |||||||||||||||||||
|
237 | NEW_CRC1_M_SRC_TXT | string (250) | Required:false |
Source of information for metastasis stage: OTHER |
238 | NEW_CRC1_CHEMO | number (1,0) | Required:false | ||||||||||
Was chemotherapy given for treatment of the new primary colorectal cancer(s)? | |||||||||||||
|
239 | NEW_CRC1_CHEMO_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of chemotherapy was applied for treatment of the new primary colorectal cancer(s)? Note: Multiple methods and agents are possible. If so they should be recorded in order given ie Neo Adjuvant first > Adjuvant > Palliative last | |||||||||||||||||
|
240 | NEW_CRC1_CHEMO1_DATE | string (8) | Required:false | ||||||
Date of 1st chemotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||
|
241 | NEW_CRC1_CHEMO1_AGT | number (1,0) | Required:false | ||||||||
Pseudo gateway question to capture overall “missing/unknown agent” | |||||||||||
|
242 | NEW_CRC1_CHEMO1_AGT_5FU | number (1,0) | Required:false | ||||||
5 FU / FLUOROURACIL/ ADRUCIL CHEMOTHERAPEUTIC AGENT first course only. Does not include medications given to control or suppress side effect. Also the list is abbreviated and another variable “other” added to list additional drugs | |||||||||
|
243 | NEW_CRC1_CHEMO1_AGT_FA | number (1,0) | Required:false | ||||||
FA (FOLINIC ACID) / LEUCOVORIN / WELLCOVORIN | |||||||||
|
244 | NEW_CRC1_CHEMO1_AGT_CPT11 | number (1,0) | Required:false | ||||||
CPT11/ IRINOTECAN / CAMPTOSAR | |||||||||
|
245 | NEW_CRC1_CHEMO1_AGT_OXAL | number (1,0) | Required:false | ||||||
OXALIPLATIN / ELOXATIN | |||||||||
|
246 | NEW_CRC1_CHEMO1_AGT_LEVA | number (1,0) | Required:false | ||||||
LEVAMISOLE | |||||||||
|
247 | NEW_CRC1_CHEMO1_AGT_XELO | number (1,0) | Required:false | ||||||
XELODA / CAPECITABINE | |||||||||
|
248 | NEW_CRC1_CHEMO1_AGT_AVAS | number (1,0) | Required:false | ||||||
AVASTIN / BEVACIZUMAB | |||||||||
|
249 | NEW_CRC1_CHEMO1_AGT_ERBI | number (1,0) | Required:false | ||||||
ERBITUX/ CETUXIMAB | |||||||||
|
250 | NEW_CRC1_CHEMO1_AGT_GEMZ | number (1,0) | Required:false | ||||||
GEMZAR | |||||||||
|
251 | NEW_CRC1_CHEMO1_AGT_OTH | number (1,0) | Required:false | ||||||
OTHER AGENT CHEMOTHERAPEUTIC AGENT | |||||||||
|
252 | NEW_CRC1_CHEMO1_AGT_OTH_TXT | string (250) | Required:false |
Free text describing OTHER CHEMOTHERAPEUTIC AGENT, COMMA SEPERATED IF MORE THAN ONE |
253 | NEW_CRC1_RAD | number (1,0) | Required:false | ||||||||||
Was radiation given for treatment of the new primary colorectal cancer(s)? | |||||||||||||
|
254 | NEW_CRC1_RAD_METHOD | number (1,0) | Required:false | ||||||||||||||
What method of radiotherapy was applied for treatment of the new primary colorectal cancer(s)? | |||||||||||||||||
|
255 | NEW_CRC1_RAD1_DATE | string (8) | Required:false | ||||||
Date of 1st radiotherapy treatment of the CRC primary(s) in the eligibility period | |||||||||
|
256 | NEW_CRC1_TREAT_OTH | number (1,0) | Required:false | ||||||||||
Were other treatment methods applied for new primary colorectal cancer(s)? | |||||||||||||
|
257 | NEW_CRC1_TREAT_OTH_TXT | string (250) | Required:false |
free text describing 1st other treatment methods applied for new CRC primary (NEW_CRC1_TREAT_OTH=1,2), Comma separated list of other agents(s |
258 | NEW_CRC1_SYNC | number (1,0) | Required:false | ||||||||||
Were synchronous new CRC primaries diagnosed? | |||||||||||||
|
259 | NEW_CRC1_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of SYNCHRONOUS PRIMARY(S) | |||||||||||
|
260 | NEW_CRC1_SYNC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
261 | NEW_CRC1_SYNC2_ICD | string (7) | Required:false |
ICD code of 2nd SYNCHRONOUS new CRC PRIMARY DIAGNOSIS TYPE. (Please record the 2nd largest. (NEW_PRIMARY_2) |
262 | NEW_CRC1_SYNC2_DXDATE | string (8) | Required:false | ||||||
DIAGNOSIS DATE OF 2nd SYNCHRONOUS new CRC PRIMARY | |||||||||
|
263 | NEW_CRC1_SYNC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd synchronous new CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
264 | NEW_CRC1_SYNC2_SURG_TYPE_TXT | string (250) | Required:false |
free text describing other surgery for 2nd synchronous new CRC |
265 | NEW_CRC1_SYNC2_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
266 | NEW_CRC1_SYNC2_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the tumor reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
267 | NEW_CRC1_SYNC3_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
268 | NEW_CRC1_SYNC3_ICD | string (7) | Required:false |
ICD code of 3rd SYNCHRONOUS new CRC PRIMARY DIAGNOSIS TYPE. (Please record the 3rd largest. (NEW_PRIMARY_3) |
269 | NEW_CRC1_SYNC3_DXDATE | string (8) | Required:false | ||||||
DIAGNOSIS DATE OF 3rd SYNCHRONOUS new CRC PRIMARY IN THE ELIGIBILITY PERIOD | |||||||||
|
270 | NEW_CRC1_SYNC3_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 3rd SYNCHRONOUS new CRC primary (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
271 | NEW_CRC1_SYNC3_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgery for 3rd synchronous new CRC |
272 | NEW_CRC1_SYNC3_SURG_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) or 3rd synchronous new CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
273 | NEW_CRC1_SYNC3_SURG_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the or 3rd synchronous new CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
274 | NEW_CRC2_PRIM | number (1,0) | Required:false | ||||||||||
Was second “non Synchronous” CRC diagnosed within the follow-up period after the diagnosis of first new CRC? NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
275 | NEW_CRC2_TUMOR_NO | number (2,0) | Required:true |
Tumor number should correspond with information from the CANCER file | |||
276 | NEW_CRC2_ICD | string (7) | Required:false |
second “non synchronous” CRC diagnosed within the follow-up period (within 4 yrs of incidence CRC) |
277 | NEW_CRC2_DXDATE | string (8) | Required:false | ||||||
Diagnosis Date 2nd new “non-synchronous” CRC primary(s) in the follow-up period | |||||||||
|
278 | NEW_CRC2_SURG_TYPE | number (2,0) | Required:false | ||||||||||||||||||||||||||||||||
Surgical treatment for 2nd non-synchronous CRC (Can use SEER coding to derive) | |||||||||||||||||||||||||||||||||||
|
279 | NEW_CRC2_SURG_TYPE_TXT | string (250) | Required:false |
Free text describing other surgical treatment for 2nd non-synchronous CRC |
280 | NEW_CRC2_SURG_TYPE_LOCAL | number (1,0) | Required:false | ||||||||||
Operative findings , local (residual tumor) 2nd non-synchronous CRC (obtain information from the operative report and/or the discharge summary NOT pathology report) | |||||||||||||
|
281 | NEW_CRC2_SURG_TYPE_MARGIN | number (1,0) | Required:false | ||||||||||||||||||
Did the 2nd non-synchronous CRC reach surgical resection margins? (Source: Pathology report) | |||||||||||||||||||||
|
282 | NEW_CRC2_SYNC | number (1,0) | Required:false | ||||||||||
Were 2nd synchronous new CRC primaries diagnosed? | |||||||||||||
|
283 | NEW_CRC2_SYNC_NUM | number (2,0) | Required:false | ||||||||
#_____ of 2nd SYNCHRONOUS PRIMARY(S) | |||||||||||
|
284 | NEW_NONCRC_PRIM | number (1,0) | Required:false | ||||||||||
Did the proband have a new non-CRC primary diagnosis after the original CRC diagnosis (after incident CRC date to date of final chart note) NOTE: Additional cancer information may exist in the individual.CANCER table | |||||||||||||
|
285 | NEW_NONCRC1_ICD | string (7) | Required:false |
ICD code for 1st new non-CRC PRIMARY |
286 | NEW_NONCRC2_ICD | string (7) | Required:false |
ICD code for 2nd new non-CRC PRIMARY |
287 | NEW_NONCRC3_ICD | string (7) | Required:false |
ICD code for 3rd new non-CRC PRIMARY |
288 | LAST_STATUS | number (1,0) | Required:true | ||||||||||||||||||||
final vital status with cause of death (COD) | |||||||||||||||||||||||
|
289 | DEATH_DATE | string (8) | Required:false | ||||||
DATE OF DEATH | |||||||||
|
290 | DEATH_CAUSE | string (25) | Required:false |
What was the patient??s cause of death? Cause of Death: (if known use ICD code) |
291 | LAST_CHART_DATE | string (8) | Required:false | ||||||
Date of Last (Most Recent) Physician Chart Note found by the Abstractor (Operative Notes, Discharge Summary, Clinic Notes, Chemotherapy and/or Radiotherapy Notes) | |||||||||
|
292 | COMPLETE_DATE | string (8) | Required:false | ||||||
Date Form Completed (date review/abstraction completed) | |||||||||
|
293 | LR_DST_RECUR | number (1,0) | Required:false | ||||||||||||
Did the patient have at least one locoregional or distal recurrence after CRC diagnosis? (Ideally interval between diagnosis date and final chart review date should be at least 4 years) | |||||||||||||||
|
294 | LR_DST1_ANAST | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional or distal recurrence (please circle all that apply): Anastomosis: | |||||||||
|
295 | LR_DST1_ANAST_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
296 | LR_DST1_MESEN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Mesentery | |||||||||
|
297 | LR_DST1_MESEN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
298 | LR_DST1_ABD_WALL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Abdominal Wall (not incisional) | |||||||||
|
299 | LR_DST1_ABD_WALL_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
300 | LR_DST1_INCS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first locoregional recurrence (please circle all that apply): Incisional | |||||||||
|
301 | LR_DST1_INCS_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
302 | LR_DST1_PELVIS | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distal or locoregional recurrence (please circle all that apply): Pelvis | |||||||||
|
303 | LR_DST1_PELVIS_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
304 | LR_DST1_LIVER | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Liver | |||||||||
|
305 | LR_DST1_LIVER_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
306 | LR_DST1_LUNG | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Lung | |||||||||
|
307 | LR_DST1_LUNG_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
308 | LR_DST1_BONE | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Bone | |||||||||
|
309 | LR_DST1_BONE_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
310 | LR_DST1_ASCITES | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Ascites | |||||||||
|
311 | LR_DST1_ASCITES_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
312 | LR_DST1_NONMES_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Non-mesenteric lymph nodes (except supraclavicular) | |||||||||
|
313 | LR_DST1_NONMES_LN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
314 | LR_DST1_NONMES_LN_TXT | string (250) | Required:false |
Free text describing specific non-mesenteric lymph nodes (except supraclavicular) |
315 | LR_DST1_SUPRA_LN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Supraclavicular nodes | |||||||||
|
316 | LR_DST1_SUPRA_LN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
317 | LR_DST1_BRAIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Brain | |||||||||
|
318 | LR_DST1_BRAIN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
319 | LR_DST1_SKIN | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence: Skin, except incision Specify site (text): | |||||||||
|
320 | LR_DST1_SKIN_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
321 | LR_DST1_SKIN_TXT | string (250) | Required:false |
Free text describing first distant or locoregional recurrence in skin, except incision |
322 | LR_DST1_ADRENAL | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence: Adrenal gland | |||||||||
|
323 | LR_DST1_ADRENAL_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|
324 | LR_DST1_OTH | number (1,0) | Required:false | ||||||
Site(s) of involvement at time of first distant or locoregional recurrence Other Specify site (text): | |||||||||
|
325 | LR_DST1_OTH_TXT | string (250) | Required:false |
Free text describing other site of first distant or locoregional recurrence |
326 | LR_DST1_OTH_DATE | string (8) | Required:false | ||||||
First Diagnosed Month First Diagnosed Day (optional) First Diagnosed Year | |||||||||
|